An international research group led by Vanderbilt University scientists has shown for the first time that a lipid, or fat molecule, can regulate “psychostimulant” behaviors by interacting with a brain protein.

A drug already used for the medical management of diabetes also reduces the rewarding effects of cocaine in animals, which could have far-reaching implications for patients worldwide who suffer from addiction.